Co-Authors
This is a "connection" page, showing publications co-authored by John Laffey and Laurent Brochard.
Connection Strength
0.820
-
The worldwide assessment of separation of patients from ventilatory assistance (WEAN SAFE) ERS Clinical Research Collaboration. Eur Respir J. 2019 03; 53(3).
Score: 0.203
-
Correction to: Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study. Intensive Care Med. 2018 01; 44(1):157-165.
Score: 0.187
-
Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study. Lancet Respir Med. 2017 08; 5(8):627-638.
Score: 0.180
-
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. JAMA. 2020 10 06; 324(13):1317-1329.
Score: 0.057
-
Demographics, management and outcome of females and males with acute respiratory distress syndrome in the LUNG SAFE prospective cohort study. Eur Respir J. 2019 10; 54(4).
Score: 0.053
-
Resolved versus confirmed ARDS after 24 h: insights from the LUNG SAFE study. Intensive Care Med. 2018 05; 44(5):564-577.
Score: 0.048
-
Research in Extracorporeal Life Support: A Call to Action. Chest. 2018 04; 153(4):788-791.
Score: 0.047
-
Etiologies, diagnostic work-up and outcomes of acute respiratory distress syndrome with no common risk factor: a prospective multicenter study. Ann Intensive Care. 2017 Dec; 7(1):69.
Score: 0.045